HoCoPsy: Caracteristics of the Patients Hospitalized With Unvonluntary Commitment Procedure, in the Context COVID-19

Sponsor
University Hospital, Montpellier (Other)
Overall Status
Completed
CT.gov ID
NCT04417374
Collaborator
(none)
94
1
2
47.7

Study Details

Study Description

Brief Summary

The actual worldwide context (disease outbreak, confinements instaured in many countries) is a stressful factor for many people. It can have consequences on mental health : separation from loved ones, loss of freedom, uncertainty about infection status, boredom. Patients with mental disorders are especially vulnerable.

On march 17th, the french government ordonned a national confinement to slow the progression of the COVID-19 outbreak, for 15 days at first then renewed several times. This situation has led to a reorganization of care as requested on March 22nd, 2020 in the recommendations applicable to the organization of care in psychiatric services : priority to telephone contacts and teleconsultation by multiplying contacts and assessments.

By the time the reorganization of care became operational, the most vulnerable patients may have experienced a decompensation of their disease.

It is important to know if the COVID-19 outbreak combined with the confinement increased the number of unvoluntary commitment the month after the announce of the confinement.

This could help us understand which patients are more vulnerable is this context, and improve our organization (ambulatory and hospitalization care) if this situation occurs again.

Condition or Disease Intervention/Treatment Phase
  • Other: Description of groups caracteristics

Detailed Description

The main objective is to notice if we can observe a increase in the number of unvonluntary commitment the month after the announce of the confinement in the psychiatric hospital La Colombière, CHU Montpellier, France.

Secondary objectives :
  • Describe the causes of unvonluntary commitment, and the principal psychiatric diagnostic of the patients

  • Assess the lengh of the hospitalization

  • Assess the number of patients hospitalized without psychiatric antecedent

  • Assess the number of treatment interruptions in the recent history before hospitalization

  • Asses the number of patients living alone

  • Asses the number of patients using drugs

It is expected to highlight :
  • An increase of the number of unvontuntary commitment

  • If one or several mental disorders were more at risk of requiring an unvonluntary commitment

  • An increased lengh of hospitalization

  • An increased number of unvonluntary commitment of patients without psychiatric antecedent

  • An increased number of treatment interruptions

  • A link between hospitalization and living alone

  • A link between hospitalization and using drugs

The medical file of all the patients unvonlutary commited from march 12th to April 09th 2020 are screened, and compared to the patients unvonlutary commited during the same period in 2019.

The caracteristics of interest are their age and sex, if the patient lives alone, the matter of hospitalization, its lengh, their primary psychiatric diagnostic, the use of toxics at the moment of the hospitalization and if this psychiatric decompensation happens in a context of treatment interruption.

Study Design

Study Type:
Observational
Actual Enrollment :
94 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Caracteristics of the Patients Hospitalized With Unvonluntary Commitment Procedure, in Pandemic and Confinement Context
Actual Study Start Date :
May 1, 2020
Actual Primary Completion Date :
May 30, 2020
Actual Study Completion Date :
Jun 30, 2020

Arms and Interventions

Arm Intervention/Treatment
Unvonluntary commitment from March 12th to April 09th 2019

Patients hospitalized with unvonluntary commitment procedure from March 12th to April 09th 2019

Other: Description of groups caracteristics
Comparison of the two groups on all the following criterias : age, sex, if the patient lives alone, the matter of hospitalization, its lengh, their primary psychiatric diagnostic, the use of toxics at the moment of the hospitalization and if this psychiatric decompensation happens in a context of treatment interruption.

Unvonluntary commitment from March 12th to April 09th 2020

Patients hospitalized with unvonluntary commitment procedure from March 12th to April 09th 2020

Other: Description of groups caracteristics
Comparison of the two groups on all the following criterias : age, sex, if the patient lives alone, the matter of hospitalization, its lengh, their primary psychiatric diagnostic, the use of toxics at the moment of the hospitalization and if this psychiatric decompensation happens in a context of treatment interruption.

Outcome Measures

Primary Outcome Measures

  1. Number of hospitalized patients [1 months]

    Number of hospitalized patients From March 12th to April 09th

Secondary Outcome Measures

  1. Cause of hospitalization [1 months]

    Primary psychiatric diagnostic From March 12th to April 09th

Other Outcome Measures

  1. Lengh of hospitalization [1 months]

    Patients without psychiatric antecedent (number) From March 12th to April 09th

  2. Treatment interruption [1 months]

    Presence of absence of history of treatment interruption leading to the hospitalization From March 12th to April 09th

  3. Number of hospitalized patients living alone [1 months]

    Number of hospitalized patients living alone (opposed to those living with family) From March 12th to April 09th

  4. Use of drugs [1 months]

    Number of patients using drugs From March 12th to April 09th

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion criteria:
  • Unvonluntary commitment in psychiatric hospital La Colombière, CHU Montpellier, from march 12th to april 19th (2019 and 2020).
Exclusion criteria:
  • refusal to participate

Contacts and Locations

Locations

Site City State Country Postal Code
1 University hospital Montpellier France 34295

Sponsors and Collaborators

  • University Hospital, Montpellier

Investigators

  • Principal Investigator: Emilie Olie, MD PhD, University Hospital, Montpellier

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
University Hospital, Montpellier
ClinicalTrials.gov Identifier:
NCT04417374
Other Study ID Numbers:
  • RECHMPL20_0320
First Posted:
Jun 4, 2020
Last Update Posted:
Jul 29, 2020
Last Verified:
Jul 1, 2020
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by University Hospital, Montpellier
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 29, 2020